Healthcare Industry News: Olympus
News Release - February 17, 2012
Getinge Group: New Executive Vice President of the Medical Systems business areaGETINGE, Sweden--(Healthcare Sales & Marketing Network)--Heinz Jacqui has been appointed the new Executive Vice President of the Medical Systems business area and will assume the position on 1 April 2012. In addition to his responsibilities for the Medical Systems business area, Heinz Jacqui will be a member of Getinge’s Group management. Heribert Ballhaus, who has successfully headed Medical Systems since 2001, will retire on the same date as scheduled.
Heinz Jacqui has a B. Sc. in Engineering and has worked in the medical-technical sector since the late 1980s, and as President of Olympus Medicals’ surgical endoscope business for the past eight years. Olympus’ surgical endoscope business generates annual sales of about SEK 8 billion and conducts significant operations in the US and Europe. Heinz Jacqui possesses extensive experience in the intensive-care area, where he held such positions as Head of Dräger’s respiratory operations.
“I am very pleased that we were able to recruit Heinz Jacqui to our Group and to our largest business area. Heinz Jacqui has vast expertise in combining products with markets at an operational and strategic level. He has made a lasting impression in the companies in which he has been active. I would also like to express my gratitude to Heribert Ballhaus for his tremendous efforts in building Medical Systems into the strong and well-positioned company it is today.”
GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical interventions and intensive care.
The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.
Source: Getinge Group
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.